Dr. Michael Laposata

University of Texas Medical Branch

Are we doing enough with testing for COVID-19 to answer the important questions for patients and healthcare practitioners?

In this presentation, Dr. Michael Laposata reviews the different testing platforms currently used for COVID-19 testing and highlights the challenges faced by healthcare practitioners in reaching accurate and reliable diagnostic conclusions. Laposata provides insight into how to overcome the occurrence of false negatives and false positives, highlights the need for high performing ELISA and chemiluminescence assays without cross-reactivity, and describes how the provision of test result interpretations could greatly reduce diagnostic errors, with significant clinical consequences.



LIKE 4


Dr. Michael Laposata
Clinical Laboratory Diagnostics COVID-19: Infectious disease

Dr. Michael Laposata

Biography

Dr. Michael Laposata is... More

Dr. Michael Laposata

University of Texas Medical Branch

Dr. Michael Laposata is Professor and Chair of the Department of Pathology at the University of Texas Medical Branch-Galveston. He received his MD and PhD from Johns Hopkins University School of Medicine and completed a postdoctoral research fellowship and residency in Laboratory Medicine (Clinical Pathology) at Washington University School of Medicine in St. Louis. Dr. Laposata is the recipient of 14 major teaching prizes at Harvard, the Massachusetts General Hospital, and the University of Pennsylvania School of Medicine. In a peer-nominated survey performed by The Pathologist, a journal reporting on the practice of pathology, the November 2015 issue identified Dr. Laposata as the most influential pathologist in the United States, and the third most influential pathologist in the world.